Pricing high in order to preserve the value of the DIC indication is surely part of Leo’s strategy. However, such a business motivation would carry no weight with the reimbursement authorities in the UK and other EU countries.
ATryn earned a premium price because it warrants a premium price (#msg-24712198).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”